Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “progesterone” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 24
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 24 pipeline programs matching "progesterone" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

24 results for “progesterone” Back to intelligence hub

Search results

  1. Oral micronized progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 3 small molecule completed

    1 trial
  2. Progesterone

    TherapeuticsMD

    Secondary Amenorrhea

    phase 3 small molecule terminated

    1 trial
  3. Progesterone

    United Therapeutics Europe Ltd

    Alcohol Dependence

    phase 3 small molecule completed

    1 trial
  4. Progesterone supplementation

    Hospital Authority, Hong Kong

    Assisted Reproductive Technology

    phase 3 other active

    1 trial
  5. didroxyprogesterone

    The First People's Hospital of Lianyungang

    Pregnancy Rate

    phase 3 small molecule active

    1 trial
  6. 9941

    CNS Pharmaceuticals

    Menopause

    phase 2 small molecule terminated

    1 trial
  7. D933LC00001

    AstraZeneca AB

    First-line (1L) Stage IV Triple Negative Breast Cancer (TNBC) - the subtype of breast cancer characterized by a lack of tumor expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2.

    phase 2 small molecule active

    1 trial
  8. Micronized Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule completed

    1 trial
  9. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use

    phase 2 small molecule completed

    1 trial
  10. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule completed

    1 trial
  11. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use Disorder

    phase 1 small molecule completed

    1 trial
  12. Progesterone vaginal ring,

    Teva Pharma GmbH

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial
  13. medroxyprogesterone acetate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial
  14. Depo-Medroxyprogesterone Acetate

    United Therapeutics Europe Ltd

    HIV

    approved small molecule completed

    1 trial
  15. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial
  16. Progesterone 100 IM/day

    Universal Integrated

    Progesterone Luteal Support in ICSI

    approved small molecule completed

    1 trial
  17. Subcutaneous depot medroxyprogesterone acetate

    Protara Therapeutics

    Contraception

    approved small molecule completed

    1 trial
  18. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Cessation

    small molecule completed

    1 trial
  19. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    small molecule completed

    1 trial
  20. Progesterone

    Hospital Authority, Hong Kong

    Preterm

    small molecule active

    1 trial
  21. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Abuse

    small molecule completed

    2 trials
  22. Vaginal progesterone

    Hospital Authority, Hong Kong

    Preterm Birth

    small molecule active

    1 trial
  23. estradiol plus progesterone 100 mg IM injection

    Universal Integrated

    IVF

    small molecule completed

    1 trial
  24. therapeutic progesterone

    United Therapeutics Europe Ltd

    Breast Cancer

    mab active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.